Susan Benton
CIK 1373649 · last filed 2026-04-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
1
Total Filings
17
Lifetime Open-Market Net
$91.4K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Opus Genetics, Inc. (OCUP) Delisted | Director | 243,894 | $1.17 | $285.4K | $91.4K | 17 | 2026-04-22 |
Recent Filings · Page 2 of 2
17 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-01-05 | Opus Genetics, Inc. (OCUP) Delisted | Grant (A) | +2,949 | $0 | EDGAR |
| 2021-10-04 | Opus Genetics, Inc. (OCUP) Delisted | Grant (A) | +2,135 | $0 | EDGAR |
| 2021-09-03 | Opus Genetics, Inc. (OCUP) Delisted | Buy (P) | +20,000 | $91.4K | EDGAR |
| 2021-07-02 | Opus Genetics, Inc. (OCUP) Delisted | Grant (A) | +2,083 | $0 | EDGAR |
| 2021-06-09 | Opus Genetics, Inc. (OCUP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-04-05 | Opus Genetics, Inc. (OCUP) Delisted | Grant (A) | +1,893 | $0 | EDGAR |
| 2020-11-13 | Opus Genetics, Inc. (OCUP) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–17 of 17
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.